What to expect
Hands wrapped around a warm mug at a wooden table

What to Expect in the First Month

A week-by-week guide to your child's first 30 days on GLP-1 treatment: what's normal, what to watch for, and when to reach out

Written by the Thryvwell Care Team · Medically reviewed by Dr. Glenda Pettaway, MD, MS, FAAP · Updated July 2026 · 6 min read

You've decided to move forward. Your child has been evaluated, the clinical team has confirmed eligibility, and the first dose is scheduled. Now what?

The first month is about adjustment, not transformation. Your child's body is learning to respond to the medication, and the clinical team is learning how your child responds. Here's what that looks like, week by week.

Before the first dose

Your child's physician will have already completed:

Comprehensive health assessment and medical history review
Baseline lab work (metabolic panel, liver function, thyroid)
Growth measurements (height, weight, BMI percentile)
Discussion of realistic expectations with your family
Prior authorization (if needed)

The medication arrives at your home. Your care team walks you through injection technique (it's a small, painless subcutaneous injection, similar to an EpiPen) and answers any last questions.

Week by week

Week 1- Starting low
Your child begins at the lowest dose. This is intentional
The clinical team confirms the medication is tolerated
Mild nausea or reduced appetite may occur but often resolves quickly
No dramatic changes expected yet. The body is adjusting
Your care team checks in to answer questions and monitor comfort
Week 2- Finding a rhythm
Most initial side effects begin to fade
Your teen may notice they feel full sooner at meals
Guidance begins to establish nutrition and activity foundations
The clinical team reviews how the first week went and adjusts if needed
Hunger patterns start to shift: less snacking, less food preoccupation
Week 3- Building momentum
Appetite regulation becomes more noticeable
Energy levels typically stabilize or improve
Behavioral support deepens, building habits that will outlast the medication
Some families notice early mood improvements as confidence builds
The clinical team may discuss the next dose level based on tolerance
Week 4- First milestone
First month check-in with your child's physician
Lab work may be ordered to confirm metabolic markers are responding
Weight change is typically modest at this stage (2-5% BMI reduction)
The focus is on tolerance, safety, and habit formation, not dramatic results
Your child's pediatrician receives an update on progress

Wondering if this applies to your child? The 2-minute eligibility check tells you if Thryvwell could be a fit. No commitment, no payment info.

What's normal (and what's not)

Normal in the first month

  • Mild nausea (especially after eating large meals)
  • Reduced interest in snacking
  • Feeling full faster than usual
  • Slight fatigue in week 1
  • Modest or no weight change yet

Contact your care team if

  • Persistent vomiting (not just nausea)
  • Severe abdominal pain
  • Signs of dehydration
  • Your child refuses to eat for more than a day
  • Mood changes that concern you

Your care team is available between appointments. You don't need to wait for a scheduled visit to ask a question or report a concern. That's the point of comprehensive care: support when you need it, not just when it's scheduled.

Setting realistic expectations

The first month is not when dramatic results happen. That's by design. The clinical protocol prioritizes safety and tolerance over speed. Here's a realistic picture:

2-5%
Typical BMI reduction in month 1
4-8 weeks
Before most families see meaningful change
12-16%
Average BMI reduction over full treatment

The first month is about building the foundation. The results come from sustained treatment, consistent habits, and ongoing clinical support. Families who understand this from the beginning tend to have the best long-term outcomes.

Two young women cooking a fresh meal together at home

Tips for the first 30 days

Keep meals smaller and more frequent
Large meals can trigger nausea early on. Smaller portions throughout the day are easier to tolerate.
Don't force food
Reduced appetite is expected. Trust the clinical team to monitor nutritional adequacy.
Stay hydrated
Water intake matters more than usual, especially if appetite is reduced.
Maintain normal routines
School, activities, social life - keep everything as normal as possible. This isn't a disruption.
Celebrate non-scale wins
Better energy, improved mood, less food preoccupation - these matter more than the number in month one.
A teen in a plaid shirt laughing, arms crossed, relaxed and confident

Sources

  • Weghuber, D. et al. "Once-Weekly Semaglutide in Adolescents with Obesity." NEJM (2022)
  • American Academy of Pediatrics. Clinical Practice Guideline for Obesity Treatment (2023)
  • Novo Nordisk. Wegovy® Prescribing Information: Dosing and Administration

Ready to get started?

A free eligibility check takes less than 2 minutes. No commitment required.

The information on this page is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any treatment. Individual results may vary.

Dr. Glenda Pettaway

Medically reviewed by Dr. Glenda Pettaway, MD, MS, FAAP

Board-certified pediatrician · Thryvwell Chief Medical Officer

Thryvwell Health

Parent-first pediatric metabolic health care for adolescents ages 12–17. We provide specialized clinical oversight, practical family support, and educational content to build lasting health habits.

Stay updated on Thryvwell Health

Enter your email for news and early access. No spam, ever.

¹ CDC NHANES 2017–2020 | ² AAP Clinical Practice Guideline for the Evaluation and Treatment of Children and Adolescents With Obesity, 2023. *Individual results may vary. Statistics reflect clinical trial outcomes (Weghuber et al., NEJM 2022) in adolescents ages 12–17 receiving semaglutide 2.4 mg plus lifestyle intervention over 68 weeks. Treatment requires a prescription and medical supervision. The information on this website is for educational purposes only and does not constitute medical advice. GLP-1 medications are prescription-only and are prescribed based on individual clinical eligibility.

© 2026 Thryvwell Health, LLC. All rights reserved. All content, images, and materials are proprietary.

HIPAA CompliantFDA-Approved Medications OnlyAligned with Medicaid Quality Metrics

See if your family qualifies

Get Started